Biograil
Tuesday, February 27, 2024
Uris
Platform for Therapeutics
Biograil is developing the proprietary technology BIONDD(TM) capsule delivering biologic drugs with a bioavailability like SC injection creating a broad platform for oral delivery of drugs that would otherwise need to be injected today.
Speakers
State
Denmark
Country
Denmark
Website
http://www.biograil.com
CEO/Top Company Official
Karsten Lindhardt
Lead Product in Development
Teriparatide (Biograil)
Partner compound 1 (Lilly)
Development Phase of Primary Product
Pre-Clinical
Number Of Unlicensed Products
Platform technology with broad potential across compounds which would need to be injected today.
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}